Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 4, 1999

View Archived Issues

EuropaBio Defends Industry, Proposes Centralized System

Atugen Gains U.S. Presence Via Collaboration, Subsidiary

Obesity Drugs Could Spring From Discovery Of Receptor

Biota Gets Much Of Value Back After U.S. Approval Of Relenza

CellStain Nears Full Trials Of Broad Cancer Diagnostic

Cantab Drops Vaccine Work In Chicken Pox, Shingles

Xenome Receives Investment From Medica For Pain Drug

Neurochem, Resolution Align To Detect Alzheimer's Early

UK Considers Allowing Secrecy Following Greenpeace Incident

Oxford Asymmetry Grows Despite Struggles In UK

BioLitec Moves Forward In Photodynamic Therapy

Alizyme Demonstrates Delivery To Colon Of Steroid Product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...